$KMB

Kimberly-Clark Q3FY26 Results: Adjusted EPS rises 17% to $1.70

Kimberly-Clark reported Q3FY26 adjusted EPS up 17% to $1.70, though net sales fell 0.4% to $4.134B. The company reaffirmed its FY26 outlook, expecting mid-single-digit growth in adjusted operating profit. Management cited China disruptions for organic sales decline. Final results are due November 5.

Original reporting
Published Oct 15, 2026, 4:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 5:20 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Kimberly-Clark Q3FY26 Results: Adjusted EPS rises 17% to $1.70 — source image
Decision brief

The 30-second read

$KMBBullishMed
01

Why it matters

Adjusted EPS rose 17% and full-year 2026 outlook was reaffirmed, but operating profit and organic sales declined, with management attributing the sales gap to disruptions tied to social media activity in China. The article also flags that preliminary estimates could change by the Nov 5 final results.

02

Market read

Traders can reassess near-term expectations for KMB’s margin trajectory and demand momentum, while monitoring how much of the EPS strength is non-operational versus sustainable.

03

What to watch

The guidance explicitly excludes acquisition impacts, including the pending Kenvue deal, so investors may need to separate core performance from deal-related expectations into separate scenarios.

Relevance 8/10Novelty 7/10Timing: preliminary Q3 results, final report scheduled for Nov 5

Background

Kimberly-Clark is a consumer products company with brands including Huggies and Kleenex, and it is providing preliminary Q3 FY26 results ahead of its final report.

Company-level read

Ticker impact

$KMBBullishMedium confidence
Context

Kimberly-Clark reported preliminary Q3 FY26 adjusted EPS of $1.70, up 17%, while reaffirming full-year 2026 outlook and flagging China social-media disruption.

Expected impact

Likely initial support from the adjusted EPS increase, tempered by concerns that organic sales fell and operating profit declined.

Evidence & confidence

The article highlights adjusted EPS growth and reiterated full-year targets, but also notes operating profit down 16.9% and organic sales down 1.3%, with EPS distortion from a one-time gain.

Market effects

Consumer staples peers may see read-through on demand resilience versus category growth, especially given the China disruption attribution.

China-linked disruption narrative could influence sentiment toward consumer discretionary and staples exposure to China demand channels.

Reaffirmed 2026 outlook may stabilize sector expectations for margin and EPS growth trajectories.

Counterpoint

The headline EPS surge is largely driven by a one-time gain, so traders may fade the move and focus on declining operating profit and weaker organic sales.

Key entities

  • Kimberly-Clark Corporation

    Reported preliminary Q3 FY26 results, reaffirmed full-year 2026 outlook, and attributed organic sales weakness to China social-media disruptions.

  • Kenvue Inc.

    Pending acquisition mentioned as excluded from the outlook impacts.

Related articles

$CRMMed

Stocks making the biggest moves midday: CoreWeave, Salesforce, Rocket Lab, Kimberly-Clark & more

Chipmakers fell, with Nvidia and AMD down 2-3%, while software firms like Salesforce and Adobe rose. FMC Corp dropped 32% after cutting Q3 guidance. Intuit gained 6% on an acquisition. Kimberly-Clark rose 4% on strong earnings. Berkshire Hathaway rose 0.4% after investing in Bending Spoons. The RealReal and Marsh & McLennan also saw gains. CoreWeave and Rocket Lab fell on AI and launch delay concerns. Penske Automotive surged 8% on a go-private deal. Walmart and Crocs rose on upgrades.

$KMBHigh

Kimberly-Clark (KMB) Exceeds Q3 Sales Forecast Despite Decline

Kimberly-Clark (KMB) forecasted Q3 sales of $4.13B, exceeding expectations despite a 1.3% YoY decline due to diaper product controversies. The stock rose 3.1% to $102.50. KMB offers a 4.87% dividend yield and is undervalued by 10% per GF Value™. Its GF Score™ is 69/100, with strengths in profitability and valuation. 11 gurus hold KMB, with mixed activity.

$KMBMed

Kimberly-Clark (KMB) Tops Q3 Estimates, Boosting Dividend Appeal

Kimberly-Clark (KMB) reported Q3 adjusted EPS of $1.70, beating estimates by $0.11, with net sales of $4.134 billion, slightly above forecasts. The company offers a 5.11% dividend yield but has a high payout ratio of 86%, raising sustainability concerns. Its GF Score™ is 69/100, reflecting solid profitability and valuation but weaker growth and momentum. Institutional investors show cautious sentiment, with more trimming than adding positions.

$KMBMedAI 8/10

Kimberly-Clark Shares Rise 1.8% as Preliminary Q3 Earnings Beat Expectations

Kimberly-Clark (KMB) shares rose 1.8% after reporting preliminary Q3 2026 earnings and revenue above expectations. Net sales were $4.13B, beating estimates by $30M, and adjusted EPS was $1.70, exceeding forecasts by $0.10. The company maintained its full-year outlook, expecting organic sales growth to lag market growth by 100 basis points due to China disruptions. Final Q3 results are due on 5 November 2026.